Pharmafile Logo
Pharmafocus logo
Advanced Search

biotech

Showing 15 posts of 861 posts found.

canada_block_001_takeda

Takeda shareholders try to buck Shire deal

June 11, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

A small group of Takeda shareholders have started making a lot of noise over its $62 billion deal for Shire, …

News
astrazeneca_logo_building

EU gives nod to expanded label for AZ’s Tagrisso

June 11, 2018
Sales and Marketing AstraZeneca, Tagrisso, biotech, drugs, pharma, pharmaceutical

AstraZeneca has scored another success with Tagrisso in Europe, by receiving an expanded marketing authorisation for Tagrisso in the first-line …

News
kendall_square_boston

Ipsen set to relocate North American HQ to Boston

June 11, 2018
Medical Communications, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen is set to join the ranks of a number of Boston-based biotechs, by setting up shop in Kendall Square. …

News
p_cagnoni_online

Rubius Therapeutics brings in new CEO

June 11, 2018
Medical Communications, Sales and Marketing Rubius Therapeutics, biotech, drugs, pharma, pharmaceutical

Rubius Therapeutics, a biotech that has ambitions to bring “super blood” to the market, has revealed that it has appointed …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

June 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

With ASCO occurring over the weekend, the headlines this week have been dominated by the news of breaking research that …

News

6.5% pay rise agreed for NHS staff

June 8, 2018
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

After years of receiving only a 1% annual pay rise, NHS staff have voted to accept a 6.5% pay offer increase …

News
pfizer_chrome_plate

Pfizer successfully appeals 2,600% price hiking case

June 8, 2018
Medical Communications Flynn Pharma, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer and co-defendant Flynn Pharma have won their appeal against a £90 million fine imposed on them by the Competition …

News

Bill Gates backed biotech reveals strategy

June 8, 2018
Medical Communications Bill and Melinda Gates Foundation, biotech, drugs, pharma, pharmaceutical

The Bill and Melina Gates Foundation already funnels a large amount of money into aiding public health, particularly by funding …

News
cancer_research_uk

Cancer Research UK unveil new Chief Business Officer

June 8, 2018
Medical Communications Cancer Research UK, biotech, drugs, pharma, pharmaceutical

Cancer Research UK has appointed Tony Hickson to the position of Chief Business Officer. He arrives to the business from …

News
nerves

Parkinson’s disease: A quest for steadier therapies

June 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parkinson's disease, biotech, drugs, pharma, pharmaceutical

The worrying number of deaths associated with Nuplazid has eyes returning to the pipeline for Parkinson’s disease. Anjali Shukla, a …

Feature

J&J looks to trim business with $2.8bn sale

June 7, 2018
Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

Johnson & Johnson continues to look at options to slim down its business, after having received an offer from Fortive …

News

Pfizer pumps $600m into venture fund, targeting neuroscience

June 7, 2018
Research and Development, Sales and Marketing Pfizer, biotech, drugs, neuroscience, pharma, pharmaceutical

Pfizer’s move to dump its neuroscience divisions caused serious ripples through the industry, with many wondering whether it heralded an …

News
money-2180330_960_720

Forty Seven springs out of the blocks ahead of IPO

June 7, 2018
Research and Development, Sales and Marketing Forty Seven, biotech, drugs, pharma, pharmaceutical

Forty Seven, a spinout from Stanford University, has had a busy few days – first announcing that it had filed …

News
handshake2

Axovant attempts to rise from ashes with $842m Parkinson’s therapy deal

June 7, 2018
Sales and Marketing Axovant, Oxford BioMedica, biotech, drugs, pharma, pharmaceutical

Axovant’s spectacular crash to Earth, after a soaring IPO that saw its share price hit the heady heights of $26, …

News

FlyPharma Conference Europe concludes its fourth successful year in Brussels

June 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, flypharma, pharma, pharmaceutical

The FlyPharma Conference Europe wrapped up for another year on 6 June, returning with an expanded roster of speakers who …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025